Is Natural Health Trends Corp. overvalued or undervalued?
Natural Health Trends Corp. is currently overvalued despite a recent upgrade in its valuation grade, as indicated by its high P/E ratio of 62 and poor return performance of -34.62% over the past year compared to the S&P 500's 10.26%.
As of 10 February 2021, the valuation grade for Natural Health Trends Corp. moved from risky to very attractive, indicating a significant improvement in its perceived value. Despite this positive change, the company appears to be overvalued based on its current financial ratios. The P/E ratio stands at 62, significantly higher than the peer average of approximately 60.78 for companies like Olaplex Holdings, Inc. and Nu Skin Enterprises, Inc., which have P/E ratios of 76.71 and 3.95, respectively. Additionally, the EV to EBITDA ratio of -18.13 and a PEG ratio of 30.35 further highlight the company's inflated valuation relative to its peers.In conclusion, Natural Health Trends Corp. is currently overvalued given its high P/E ratio and negative EV metrics, despite the recent upgrade in its valuation grade. The company's return performance has also lagged behind the S&P 500, with a 1-year return of -34.62% compared to the index's 10.26%, reinforcing the notion that the stock may not be a favorable investment at this time.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
